期刊
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA
卷 26, 期 2, 页码 257-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.soc.2016.10.006
关键词
Esophageal cancer; Radiation; Chemotherapy; IMRT; Dose-escalation
The treatment of locally advanced esophageal cancer is controversial. For patients who are candidates for surgical resection, multiple prospective clinical trials have demonstrated the advantages of neoadjuvant chemoradiation. For patients who are medically inoperable, definitive chemoradiation is an alternative approach with survival rates comparable to trimodality therapy. Although trials of dose escalation are ongoing, the standard radiation dose remains 50.4 Gy. Modern radiotherapy techniques such as
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据